myo-inositol 1,4,6-trisphosphorothioate and myo-inositol 1,3,6- trisphosphorothioate: Partial agonists with very low intrinsic activity at the platelet myo-inositol 1,4,5-trisphosphate receptor

Molecular Pharmacology

Volumn 57, Issue 3, 2000, Pages 595-601

  Murphy, Christine T ^a   Riley, Andrew M ^a   Mills, Steve J ^a   Lindley, Catherine J ^a   Potter, Barry V L ^a   Westwick, John ^a  

^a University of Bath ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INOSITOL 1,3,6 TRISPHOSPHOROTHIOATE AGONIST; INOSITOL 1,4,6 TRISPHOSPHOROTHIOATE AGONIST; INOSITOL DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; DRUG ACTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; ENANTIOMER; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTE;

EID: 0034087688     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.57.3.595     Document Type: Article

References (38)

1. 2+ release. Br J Pharmacol 112:P435.
2. Berridge MJ (1993) Inositol trisphosphate and calcium signalling. Nature (Lond) 361:315-325.
3. Blondel O, Takeda J, Janssen H, Seino S and Bell GI (1993) Sequence and functional characterisation of a third inositol trisphosphate receptor subtype, IP3R-3, expressed in pancreatic islets, kidney, gastrointestinal tract, and other tissues. J Biol Chem 288:11356-11363.
4. Challiss RAJ, Willcocks AL, Mulloy B, Potter BVL and Nahorski SR (1991) Characterization of inositol 1,4,5-trisphosphate-binding and inositol 1,3,4,5-tetrakisphosphate-binding sites in rat cerebellum. Biochem J 274:861-867.
5. Clapham DE (1995) Calcium signaling. Cell 80:259-268.
6. 3. Br J Pharmacol 125:P23.
7. Furuichi T, Yoshikawa S, Miyawaki A, Wada K, Maeda N and Mikoshiba K (1989) Primary structure and functional expression of the inositol 1,4,5-trisphosphate-binding protein P400. Nature (Lond) 342:32-38.
8. 2+ mobilization in SH-SY5Y cells. Biochem J 276:163-167.
9. 2+ entry induced by cyclic ADP-ribose in intact T-lymphocytes. J Biol Chem 272:8546-8550.
10. 2+ signalling in T-lymphocytes by the second messenger cyclic ADP-ribose. Nature (Lond) 398:70-73.
11. 2+. J Biol Chem 264:20303-20308.
12. Hirata M, Watanabe Y, Yoshida M, Koga T and Ozaki S (1993) Roles for hydroxyl groups of D-myo-inositol 1,4,5-trisphosphate in the recognition by its receptor and metabolic enzymes. J Biol Chem 268:19260-19266.
13. Joseph SK, Lin C, Pierson S, Thomas AP and Maranto AR (1995) Heteroligomers of type-I and type-III inositol trisphosphate receptors in WB rat-liver epithelial cells. J Biol Chem 270:23310-23316.
14. 3 receptor partial agonist in SH-SY5Y neuroblastoma cells. J Med Chem 37:868-872.
15. Liu C, Al-Hafidh J, Westwick J and Potter BVL (1994) Synthesis of 1L-chiro 2,3,5-trisphosphorothioate, the first partial agonist at the platelet myo-inositol 1,4,5-trisphosphate receptor. Bioorg Med Chem 2:253-257.
16. 3 receptors. Biochem J 321:573-576.
17. 2+ release from cerebellar microsomes. J Biol Chem 271:31818-31823.
18. Mills SJ and Potter BVL (1996) Synthesis of D-and L-myo-inositol 1,4,6-trisphosphate, regioisomers of a ubiquitous second messenger. J Org Chem 61: 8980-8987.
19. 2+-mobilising partial agonists at the inositol 1,4,5-trisphosphate receptor. Bioorg Med Chem Lett 5:203-208.
20. Miyawaki A, Furuichi T, Maeda N and Mikoshiba K (1990) Expressed cerebellar-type inositol 1,4,5-trisphosphate receptor, P400, has calcium release activity in a fibroblast L cell line. Neuron 5:11-18.
21. Monkawa T, Miyawaki A, Sugiyama T, Yoneshima H, Yamamoto-Hino M, Furuichi T, Saruta T and Hasegawa M (1995) Heterotetrameric complex formation of inositol 1,4,5-trisphosphate receptor subunits. J Biol Chem 270:14700-14704.
22. Murphy CT, Bullock AJ, Lindley CJ, Mills SJ, Riley AM, Potter BVL and Westwick J (1996) Enantiomers of inositol-1,3,4-trisphosphate and inositol 1,4,6-trisphosphate: Stereospecific recognition by cerebellar and platelet inositol 1,4,5-trisphosphate receptors. Mol Pharmacol 50:1223-1230.
23. Murphy CT, Elmore M, Kellie S and Westwick J (1991) The relationship between cytosolic calcium, sn-1,2-diacylglycerol and inositol 1,4,5-trisphosphate elevation in PAF stimulated rabbit platelets. Biochem J 278:255-261.
24. Murphy CT and Westwick J (1994) Role of type 1 and 2a phosphatases in signal transduction of platelet-activating factor-stimulated rabbit platelets. Biochem J 301:531-537.
25. Patel S, Joseph SK and Thomas AP (1999) Molecular properties of inositol 1,4,5-trisphosphate receptors. Cell Calcium 25:247-264.
26. Polokoff MA, Bencen GH, Vacca JP, DeSolms SJ and Young SD (1988) Metabolism of synthetic inositol trisphosphate analogues. J Biol Chem 263:11922-11927.
27. Potter BVL and Lampe D (1995) Chemistry of inositol lipid mediated cellular signalling. Angew Chem Int Ed Engl 34:1933-1972.
28. Potter BVL and Nahorski SR (1992) Synthesis and biology of inositol polyphosphate analogs. Biochem Soc Trans 20:434-442.
29. Putney JW and Bird GStJ (1993) The signal for capacitative calcium entry. Cell 75:199-201.
30. 2+ in Limulus photoreceptors. J Med Chem 37: 3918-3927.
31. Safrany ST, Wilcox RA, Liu C, Dubreuil D, Potter BVL and Nahorski SR (1993) Identification of partial agonists with low intrinsic activity at the inositol-1,4,5-trisphosphate receptor. Mol Pharmacol 43:499-503.
32. 2+-releasing D-myo-inositol 1,4,5-trisphosphate receptor, and the metabolic enzymes 5-phosphatase and 3-kinase. FEBS Lett 278:252-256.
33. 2+ release in NIH 3T3 cells. J Chem Soc Faraday Trans I 22:1638-1639.
34. 3 receptor. EMBO (Eur Mol Biol Organ) J 10:3199-3206.
35. Wilcox RA, Fauq A, Kozikowski AP and Nahorski SR (1997) Defining the minimal structural requirements for partial agonism at the type I myo-inositol 1,4,5-trisphosphate receptor. FEBS Lett 402:241-245.
36. Wilcox RA, Primrose WU, Nahorski SR and Challiss JRA (1998) New developments in the molecular pharmacology of the myo-inositol 1,4,5-trisphosphate receptor. Trends Pharmacol Sci 19:467-475.
37. Wilcox RA, Safrany ST, Lampe D, Mills SJ, Nahorski SR and Potter BVL (1994) Modification at C2 of myo-inositol 1,4,5-trisphosphate produces inositol trisphosphates and tetrakisphosphates with potent biological activities. Eur J Biochem 223:115-124.
38. Wojcikiewicz RJH and He Y (1995) Type I, II and III inositol 1,4,5-trisphosphate receptor co-immunoprecipitation as evidence for the existence of heterotetrameric receptor complexes. Biochem Biophys Res Commun 213:334-341.